Switzerland
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 11.71 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
2 |
USD 651.21 M
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
3 |
USD 149.21 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
4 |
USD 84.94 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
5 |
USD 15.69 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
6 |
USD -9.50 M
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
7 |
USD -9.68 M
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
8 |
USD -10.89 M
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
9 |
USD -22.02 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
10 |
USD -22.35 M
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
11 |
USD -31.73 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
12 |
USD -35.57 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
13 |
USD -43.06 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
14 |
USD -63.67 M
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
15 |
USD -64.01 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
16 |
USD -71.04 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
17 |
USD -72.70 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
18 |
USD -121.90 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
19 |
USD -242.64 M
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
20 |
USD -272.35 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
21 |
USD -312.38 M
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
22 |
USD -368.22 M
|
Dec. 31, 2023 | USD 2.41 | 0.50% |
|
Switzerland |
The Biotechnology company in Switzerland with the highest Free Cash Flow is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 11.71 B.
The Biotechnology company in Switzerland with the lowest Free Cash Flow is Meyer Burger Technology AG (Swiss Stock Exchange: MBTN.SW) at USD -368.22 M.
The top 10 Biotechnology companies in Switzerland by Free Cash Flow are Novartis AG, DSM-Firmenich AG, Tecan Group AG, Siegfried Holding AG, Basilea Pharmaceutica AG, Addex Therapeutics Ltd, NLS Pharmaceutics AG, Kuros Biosciences AG, Bachem Holding AG and PolyPeptide Group AG.
The bottom 10 Biotechnology companies in Switzerland by Free Cash Flow are Meyer Burger Technology AG, Lonza Group AG, CRISPR Therapeutics AG, Sandoz Group AG, ADC Therapeutics SA, AC Immune SA, Molecular Partners AG, Oculis Holding AG, Dottikon Es Holding AG and MoonLake Immunotherapeutics.